MASSMEDICA SPÓŁKA AKCYJNA
UL. CHORĄGWI PANCERNEJ 43, 02-951 WARSZAWA
TAX ID1132835251
MASSMEDICA SPÓŁKA AKCYJNA
TAX ID1132835251
KRS0000688627
Share capital241,489.90 zł
address
UL. CHORĄGWI PANCERNEJ 43, 02-951 WARSZAWA
Website
www.massmedica.comCategories
Main category
Other categories
Register Data
NIP
1132835251 
REGON
142951515
KRS
0000688627
Legal form
joint stock company
Register Address
UL. CHORĄGWI PANCERNEJ 43, 02-951 WARSZAWA
Date of registration in KRS
2017-07-31
Date of commencement of economic activity
2017-07-31
Act signature
RDF/759728/25/800
Website
WWW.MASSMEDICA.COM
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Aktywa  | 16,8 | 17,9 | 19 | 6 |
Zysk (strata) brutto | 0,5 | 0,6 | 0,5 | -13,9 |
Kapitał (fundusz) własny | 4,6 | 4,7 | 4,8 | 1,4 |
Środki pieniężne | 0,1 | 0,1 | 0 | -69,5 |
Zysk operacyjny (EBIT) | 0,6 | 0,9 | 0,9 | 1,4 |
Aktywa obrotowe | 12,9 | 14,3 | 17,3 | 21,5 |
EBITDA | 1 | 1,3 | 1,4 | 8,3 |
Przychody netto ze sprzedaży | 21,6 | 24,8 | 26,4 | 6,2 |
Zobowiązania krótkoterminowe | 11,9 | 13,2 | 10,9 | -17,9 |
Zobowiązania i rezerwy na zobowiązania | 12,2 | 13,2 | 14,3 | 7,6 |
Zysk (strata) netto | 0,3 | 0,4 | 0,3 | -23,9 |
Amortyzacja | 0,4 | 0,4 | 0,5 | 24 |
% | % | % | p.p. | |
Marża EBITDA | 4,6 | 5,1 | 5,2 | 0,1 |
Wskaźnik Rentowności sprzedaży (ROS) | 1,6 | 1,7 | 1,2 | -0,5 |
Marża zysku brutto | 2,3 | 2,3 | 1,9 | -0,4 |
Rentowność kapitału (ROE) | 7,6 | 8,7 | 6,6 | -2,1 |
Kapitał własny do aktywów ogółem | 27,5 | 26,1 | 25 | -1,1 |
Days | Days | Days | Days | |
Cykl rotacji zobowiązań krótkoterminowych | 202 | 194 | 150 | -44 |
Financial statements
01-01-2024 - 31-12-2024
A resolution or a decision approving the consolidated annual financial statements
Download pdf01-01-2024 - 31-12-2024
Auditor's opinion / report on the audit of the consolidated annual financial statements of the capital group
Download pdf01-01-2024 - 31-12-2024
Consolidated annual financial statements
Download pdf01-01-2024 - 31-12-2024
Consolidated annual financial statements
Download xml01-01-2024 - 31-12-2024
Report on the activities of the capital group
Download pdf01-01-2024 - 31-12-2024
Resolution or decision approving the annual financial statements
Download pdf01-01-2024 - 31-12-2024
Resolution on profit distribution or loss coverage
Download pdf01-01-2024 - 31-12-2024
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2024 - 31-12-2024
Activity report
Download pdf01-01-2024 - 31-12-2024
Annual financial report
Download pdf01-01-2024 - 31-12-2024
Annual financial report
Download xmlShow more (8)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.